2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications

Sarah Ringold, Pamela F. Weiss, Timothy Beukelman, Esi Morgan Dewitt, Norman Todd Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Peter A. Nigrovic, Angela Byun Robinson, Richard K. Vehe

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

Original languageEnglish (US)
Pages (from-to)2499-2512
Number of pages14
JournalArthritis and Rheumatism
Volume65
Issue number10
DOIs
StatePublished - Oct 2013

Fingerprint

Juvenile Arthritis
Tuberculosis
Rheumatology
Guidelines
Guideline Adherence
Medical Societies
Therapeutics
Technology
Physicians

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology
  • Pharmacology (medical)

Cite this

2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis : Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. / Ringold, Sarah; Weiss, Pamela F.; Beukelman, Timothy; Dewitt, Esi Morgan; Ilowite, Norman Todd; Kimura, Yukiko; Laxer, Ronald M.; Lovell, Daniel J.; Nigrovic, Peter A.; Robinson, Angela Byun; Vehe, Richard K.

In: Arthritis and Rheumatism, Vol. 65, No. 10, 10.2013, p. 2499-2512.

Research output: Contribution to journalArticle

Ringold, Sarah ; Weiss, Pamela F. ; Beukelman, Timothy ; Dewitt, Esi Morgan ; Ilowite, Norman Todd ; Kimura, Yukiko ; Laxer, Ronald M. ; Lovell, Daniel J. ; Nigrovic, Peter A. ; Robinson, Angela Byun ; Vehe, Richard K. / 2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis : Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. In: Arthritis and Rheumatism. 2013 ; Vol. 65, No. 10. pp. 2499-2512.
@article{1e134b8086004e64bbdda1389038c0fd,
title = "2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications",
abstract = "Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.",
author = "Sarah Ringold and Weiss, {Pamela F.} and Timothy Beukelman and Dewitt, {Esi Morgan} and Ilowite, {Norman Todd} and Yukiko Kimura and Laxer, {Ronald M.} and Lovell, {Daniel J.} and Nigrovic, {Peter A.} and Robinson, {Angela Byun} and Vehe, {Richard K.}",
year = "2013",
month = "10",
doi = "10.1002/art.38092",
language = "English (US)",
volume = "65",
pages = "2499--2512",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - 2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis

T2 - Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications

AU - Ringold, Sarah

AU - Weiss, Pamela F.

AU - Beukelman, Timothy

AU - Dewitt, Esi Morgan

AU - Ilowite, Norman Todd

AU - Kimura, Yukiko

AU - Laxer, Ronald M.

AU - Lovell, Daniel J.

AU - Nigrovic, Peter A.

AU - Robinson, Angela Byun

AU - Vehe, Richard K.

PY - 2013/10

Y1 - 2013/10

N2 - Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

AB - Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

UR - http://www.scopus.com/inward/record.url?scp=84885103190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885103190&partnerID=8YFLogxK

U2 - 10.1002/art.38092

DO - 10.1002/art.38092

M3 - Article

C2 - 24092554

AN - SCOPUS:84885103190

VL - 65

SP - 2499

EP - 2512

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 10

ER -